{
  "input": {
    "mode": "report_and_evolve",
    "query": {
      "entity": "Atypical haemolytic uraemic syndrome",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_eculizumab",
          "name": "Eculizumab"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_ravulizumab",
          "name": "Ravulizumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_mycophenolate_mofetil",
          "name": "Mycophenolate mofetil"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_thrombopoietin_receptor_agonists",
          "name": "Thrombopoietin receptor agonists"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_plasmapheresis",
          "name": "Plasmapheresis"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_anticoagulants",
          "name": "Anticoagulants"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_aspirin",
          "name": "Aspirin"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_sirolimus",
          "name": "Sirolimus"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_belatacept",
          "name": "Belatacept"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "scores": [
      {
        "hypothesis_id": "H1",
        "score": 0.77,
        "components": {
          "mechanism_fit": 0.9,
          "class_prior": 0.8,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.8,
          "safety_risk": 0.2,
          "graph_bonus": 0.0,
          "conflict_penalty": 0.06
        },
        "graph_signals": {
          "support_weight": 0.9,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "离靶效应",
              "pro": [
                "drug_eculizumab"
              ],
              "con": [
                "n_ph__enotype"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Eculizumab 显著靶向 C5 补体蛋白，具备治疗 aHUS 的机制依据"
          ],
          "safety_risk": [
            "存在潜在离靶效应的担忧"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H2",
        "score": 0.76,
        "components": {
          "mechanism_fit": 0.9,
          "class_prior": 0.8,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.8,
          "safety_risk": 0.2,
          "graph_bonus": 0.0,
          "conflict_penalty": 0.06
        },
        "graph_signals": {
          "support_weight": 0.9,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": [
            {
              "topic": "离靶效应",
              "pro": [
                "drug_ravulizumab"
              ],
              "con": [
                "n_ph__enotype"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "Ravulizumab 也显著靶向 C5 补体蛋白，机制相似于 Eculizumab"
          ],
          "safety_risk": [
            "负面反应的潜在可能性需要考虑"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H3",
        "score": 0.52,
        "components": {
          "mechanism_fit": 0.3,
          "class_prior": 0.4,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.7,
          "safety_risk": 0.1,
          "graph_bonus": 0.0,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.6,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 0,
          "conflict_hotspots": [
            {
              "topic": "离靶效应",
              "pro": [
                "drug_corticosteroids"
              ],
              "con": [
                "n_ph__enotype"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "类固醇可支持血小板减少症的治疗，但机制不如专门靶向治疗明确"
          ],
          "safety_risk": [
            "存在离靶效应的反驳可能性"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H4",
        "score": 0.45,
        "components": {
          "mechanism_fit": 0.3,
          "class_prior": 0.4,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.3,
          "safety_risk": 0.1,
          "graph_bonus": 0.0,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.6,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 0,
          "conflict_hotspots": [
            {
              "topic": "离靶效应",
              "pro": [
                "drug_mycophenolate_mofetil"
              ],
              "con": [
                "n_ph__enotype"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "主要用于免疫抑制，未直接针对 aHus 的机制"
          ],
          "safety_risk": [
            "有潜在离靶效应导致不良影响"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H5",
        "score": 0.5,
        "components": {
          "mechanism_fit": 0.2,
          "class_prior": 0.3,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.5,
          "safety_risk": 0.2,
          "graph_bonus": 0.0,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.6,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 0,
          "conflict_hotspots": [
            {
              "topic": "离靶效应",
              "pro": [
                "drug_cyclophosphamide"
              ],
              "con": [
                "n_ph__enotype"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "主要用于免疫介导的疾病，未直接涉及 aHus 的机制"
          ],
          "safety_risk": [
            "潜在离靶效应影响疗效"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H6",
        "score": 0.48,
        "components": {
          "mechanism_fit": 0.3,
          "class_prior": 0.3,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.4,
          "safety_risk": 0.2,
          "graph_bonus": 0.0,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.65,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 0,
          "conflict_hotspots": [
            {
              "topic": "离靶效应",
              "pro": [
                "drug_thrombopoietin_receptor_agonists"
              ],
              "con": [
                "n_ph__enotype"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "能够促进血小板生成，但未明确针对 aHus 行为机制"
          ],
          "safety_risk": [
            "潜在离靶效应有待考量"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H7",
        "score": 0.72,
        "components": {
          "mechanism_fit": 0.6,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.8,
          "safety_risk": 0.3,
          "graph_bonus": 0.0,
          "conflict_penalty": 0.03
        },
        "graph_signals": {
          "support_weight": 0.7,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "血浆置换疗法实践用于治疗 aHus"
          ],
          "safety_risk": [
            "离靶效应相对较少提及"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H8",
        "score": 0.5,
        "components": {
          "mechanism_fit": 0.3,
          "class_prior": 0.4,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.5,
          "safety_risk": 0.2,
          "graph_bonus": 0.0,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.55,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 0,
          "conflict_hotspots": [
            {
              "topic": "离靶效应",
              "pro": [
                "drug_anticoagulants"
              ],
              "con": [
                "n_ph__enotype"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "抗凝剂可能帮助减轻并发症的影响，但机制较为模糊"
          ],
          "safety_risk": [
            "潜在的离靶效应值得关注"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H9",
        "score": 0.45,
        "components": {
          "mechanism_fit": 0.3,
          "class_prior": 0.3,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.5,
          "safety_risk": 0.2,
          "graph_bonus": 0.0,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.5,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 0,
          "conflict_hotspots": [
            {
              "topic": "离靶效应",
              "pro": [
                "drug_aspirin"
              ],
              "con": [
                "n_ph__enotype"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "阿司匹林在aHUS中未展示明显机制关联"
          ],
          "safety_risk": [
            "焦点离靶效应仍需大力研究特性"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H10",
        "score": 0.42,
        "components": {
          "mechanism_fit": 0.3,
          "class_prior": 0.3,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.4,
          "safety_risk": 0.2,
          "graph_bonus": 0.0,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.5,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 0,
          "conflict_hotspots": [
            {
              "topic": "离靶效应",
              "pro": [
                "drug_sirolimus"
              ],
              "con": [
                "n_ph__enotype"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "使用非常限于抗免疫相关情境，未显著对应 aHUS 的机制"
          ],
          "safety_risk": [
            "离靶效应的潜在风险需加以排查"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H11",
        "score": 0.5,
        "components": {
          "mechanism_fit": 0.3,
          "class_prior": 0.4,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.5,
          "safety_risk": 0.2,
          "graph_bonus": 0.0,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.5,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 0,
          "conflict_hotspots": [
            {
              "topic": "离靶效应",
              "pro": [
                "drug_rituximab"
              ],
              "con": [
                "n_ph__enotype"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "未明确针对 aHUS 的机制，机制模糊"
          ],
          "safety_risk": [
            "离靶效应的潜在风险需关注"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H12",
        "score": 0.4,
        "components": {
          "mechanism_fit": 0.3,
          "class_prior": 0.3,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.4,
          "safety_risk": 0.2,
          "graph_bonus": 0.0,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.5,
          "contradiction_weight": 0.85,
          "mechanistic_connectivity": false,
          "path_disjointness": 0,
          "conflict_hotspots": [
            {
              "topic": "离靶效应",
              "pro": [
                "drug_belatacept"
              ],
              "con": [
                "n_ph__enotype"
              ]
            }
          ]
        },
        "rationales": {
          "mechanism_fit": [
            "作为免疫抑制剂应用，其针对性较弱"
          ],
          "safety_risk": [
            "有潜在离靶效应的风险"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      }
    ],
    "ranking": [
      "H1",
      "H2",
      "H7",
      "H3",
      "H5",
      "H8",
      "H11",
      "H6",
      "H4",
      "H9",
      "H10",
      "H12"
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mycophenolate_mofetil",
          "type": "Drug",
          "label": "Mycophenolate mofetil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_thrombopoietin_receptor_agonists",
          "type": "Drug",
          "label": "Thrombopoietin receptor agonists",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_plasmapheresis",
          "type": "Drug",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_anticoagulants",
          "type": "Drug",
          "label": "Anticoagulants",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_aspirin",
          "type": "Drug",
          "label": "Aspirin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sirolimus",
          "type": "Drug",
          "label": "Sirolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_belatacept",
          "type": "Drug",
          "label": "Belatacept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Target_C5",
          "type": "Target",
          "label": "C5 Complement Protein",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Pathway_complement_system",
          "type": "Pathway",
          "label": "Complement System",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Disease_aHUS",
          "type": "Disease",
          "label": "Atypical Haemolytic Uraemic Syndrome",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Phenotype_renal_failure",
          "type": "Phenotype",
          "label": "Renal Failure",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Phenotype_thrombocytopenia",
          "type": "Phenotype",
          "label": "Thrombocytopenia",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_mycophenolate_mofetil",
          "type": "Drug",
          "label": "Mycophenolate mofetil",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_thrombopoietin_receptor_agonists",
          "type": "Drug",
          "label": "Thrombopoietin receptor agonists",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_plasmapheresis",
          "type": "Drug",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_anticoagulants",
          "type": "Drug",
          "label": "Anticoagulants",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_aspirin",
          "type": "Drug",
          "label": "Aspirin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_sirolimus",
          "type": "Drug",
          "label": "Sirolimus",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_belatacept",
          "type": "Drug",
          "label": "Belatacept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_phenotype",
          "type": "Phenotype",
          "label": "Adverse Phenotypes of Atypical Haemolytic Uraemic Syndrome",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_eculizumab",
          "type": "Target",
          "label": "Off-target effects of Eculizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_ravulizumab",
          "type": "Target",
          "label": "Off-target effects of Ravulizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_corticosteroids",
          "type": "Target",
          "label": "Off-target effects of Corticosteroids",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp",
          "type": "Pathway",
          "label": "Risk associated pathways",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Eculizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Mycophenolate mofetil",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Thrombopoietin receptor agonists",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Anticoagulants",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Aspirin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Sirolimus",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Rituximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Belatacept",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_eculizumab",
          "target": "Target_C5",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "针对C5补体蛋白的靶向作用"
        },
        {
          "source": "drug_ravulizumab",
          "target": "Target_C5",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "针对C5补体蛋白的靶向作用"
        },
        {
          "source": "Target_C5",
          "target": "Pathway_complement_system",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "补体系统的关键成分"
        },
        {
          "source": "Pathway_complement_system",
          "target": "Disease_aHUS",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "补体系统异常与aHUS相关"
        },
        {
          "source": "Pathway_complement_system",
          "target": "Phenotype_renal_failure",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与肾功能衰竭的直接关联"
        },
        {
          "source": "Pathway_complement_system",
          "target": "Phenotype_thrombocytopenia",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "与血小板减少症的直接关联"
        },
        {
          "source": "drug_corticosteroids",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "用于管理相关并发症"
        },
        {
          "source": "drug_mycophenolate_mofetil",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "用于免疫抑制治疗"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "对于免疫相关疾病的治疗"
        },
        {
          "source": "drug_thrombopoietin_receptor_agonists",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "刺激血小板生成的潜在疗法"
        },
        {
          "source": "drug_plasmapheresis",
          "target": "Disease_aHUS",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "血浆置换在aHUS治疗中的应用"
        },
        {
          "source": "drug_anticoagulants",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "防止血栓形成的处理"
        },
        {
          "source": "drug_aspirin",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "在血小板减少症的辅助使用"
        },
        {
          "source": "drug_sirolimus",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "用于控制免疫反应"
        },
        {
          "source": "drug_rituximab",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.5,
          "agent": "治疗免疫性疾病"
        },
        {
          "source": "drug_belatacept",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.5,
          "agent": "作为免疫抑制剂的应用"
        },
        {
          "source": "n_eculizumab",
          "target": "n_ot_eculizumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能存在离靶作用导致不良反应"
        },
        {
          "source": "n_ravulizumab",
          "target": "n_ot_ravulizumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能存在离靶作用导致不良反应"
        },
        {
          "source": "n_corticosteroids",
          "target": "n_ot_corticosteroids",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能存在离靶作用导致不良反应"
        },
        {
          "source": "n_ot_eculizumab",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的风险通路"
        },
        {
          "source": "n_ot_ravulizumab",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的风险通路"
        },
        {
          "source": "n_ot_corticosteroids",
          "target": "n_rp",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的风险通路"
        },
        {
          "source": "n_rp",
          "target": "n_phenotype",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "与不良表型相关时可能加重病情"
        },
        {
          "source": "n_ph__enotype",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果存在离靶效应，则Eculizumab的疗效将受到影响"
        },
        {
          "source": "n_ph__enotype",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果存在离靶效应，则Ravulizumab的疗效将受到影响"
        },
        {
          "source": "n_ph__enotype",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如果存在离靶效应，则Corticosteroids的疗效将受到影响"
        }
      ],
      "round_index": 4
    },
    "history": {
      "round": 4
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_eculizumab",
          "name": "Eculizumab"
        },
        "score": 0.77,
        "graph_snapshot_ref": "GE_H1_round4",
        "key_assumptions": [
          "Eculizumab 通过靶向 C5 补体蛋白可有效治疗 aHUS",
          "潜在离靶效应需要进一步探讨"
        ],
        "caveats": [
          "离靶效应的影响不明确，需谨慎监测"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_ravulizumab",
          "name": "Ravulizumab"
        },
        "score": 0.76,
        "graph_snapshot_ref": "GE_H2_round4",
        "key_assumptions": [
          "Ravulizumab 也靶向 C5 补体蛋白，机制与 Eculizumab 相似",
          "离靶效应反应需加以关注"
        ],
        "caveats": [
          "临床应用需考虑负面反应可能性"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H7",
        "candidate": {
          "id": "drug_plasmapheresis",
          "name": "Plasmapheresis"
        },
        "score": 0.72,
        "graph_snapshot_ref": "GE_H7_round4",
        "key_assumptions": [
          "血浆置换疗法在 aHUS 中的使用实践有支持依据",
          "相对较少离靶效应的报道"
        ],
        "caveats": [
          "需监测治疗过程中可能出现的并发症"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug→Target_C5→Pathway_complement_system→Disease_aHUS",
          "reason": "Eculizumab 和 Ravulizumab 通过靶向 C5 补体蛋白形成完整的治疗路径"
        }
      ],
      "remaining_gaps": [
        "潜在的离靶效应需更多证据支持工具与监测策略"
      ]
    },
    "seed_retrospective": {
      "batches": [],
      "lessons": []
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "强化对靶标的监测，确保离靶效应最小化。"
      },
      {
        "role": "Skeptic",
        "patch": "提出建议对潜在离靶效应的最小化和应对策略进行检验。"
      }
    ],
    "heuristics": [
      {
        "when": "涉及血管与免疫系统相关疾病时",
        "then": "优先考虑靶向机制明确的治疗选项，减少离靶效应风险"
      }
    ]
  }
}